Establishing a Biobank to Study Genetic and Environmental Factors in Bilio-pancreatic Diseases

What this Trial Is About

Researchers are investigating the role of genetic predisposition and environmental factors in multifactorial bilio-pancreatic diseases, including inflammatory, functional, and neoplastic conditions such as pancreatitis and pancreatic adenocarcinoma. The study aims to better understand how these combined factors contribute to disease development for improved prevention and early diagnosis. This observational study is sponsored by IRCCS San Raffaele and collects both retrospective and prospective biological samples and clinical data. Participants provide various biological samples depending on their condition, including peripheral and portal blood, saliva, urine, stool, cystic fluid, pancreatic juice, and biopsy tissues. The biobank collects and stores these samples to facilitate analysis of genetic and environmental influences on bilio-pancreatic diseases. There is no treatment or intervention administered, as this is an observational study. During the study, researchers collect and analyze clinical data and biological samples to measure the rate of patients with pancreatic disorders who show specific exposures or biomarkers. The study lasts about one year on average, with ongoing monitoring through study completion. Participants involvement includes providing consent and samples, with no additional treatment or procedures required.

Activation of Biobank Registry for Bilio-pancreatic Diseases